These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 33949720)

  • 21. Stability-indicating HPLC method development and validation for simultaneous estimation of metformin, dapagliflozin, and saxagliptin in bulk drug and pharmaceutical dosage form.
    Vankalapati KR; Alegete P; Boodida S
    Biomed Chromatogr; 2022 Jul; 36(7):e5384. PubMed ID: 35434817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of LC-MS/MS method for simultaneous determination of Canagliflozin and Metformin in human plasma and its pharmacokinetic application in Indian population under fast and fed conditions.
    Wattamwar T; Mungantiwar A; Gujar S; Pandita N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Oct; 1154():122281. PubMed ID: 32763846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous determination of linagliptin and metformin by reverse phase-high performance liquid chromatography method: An application in quantitative analysis of pharmaceutical dosage forms.
    Vemula P; Dodda D; Balekari U; Panga S; Veeresham C
    J Adv Pharm Technol Res; 2015; 6(1):25-8. PubMed ID: 25709966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of a single HPLC-PDA method for quantifying Metformin, Gliclazide, Pioglitazone, Dapagliflozin, Empagliflozin, Saxagliptin, Linagliptin and Teneligliptin using central composite design.
    Kant R; Bodla RB; Kapoor G; Bhutani R
    Bioorg Chem; 2019 Oct; 91():103111. PubMed ID: 31336308
    [No Abstract]   [Full Text] [Related]  

  • 25. Mean centering-triple divisor and ratio derivative-zero crossing for simultaneous determination of some diabetes drugs in their quaternary mixture with severely overlapping spectra.
    M Amin KF; Abdullah AM; Fakhre NA
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Nov; 222():117261. PubMed ID: 31228859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of an HPLC-UV Method to Assay Empagliflozin Tablets and Identification of the Major Photoproduct by Quadrupole Time-of-Flight Mass Spectrometry.
    Burin SL; Lourenço RL; Doneda M; Müller EI; Paula FR; Adams AIH
    J Chromatogr Sci; 2021 May; 59(6):526-535. PubMed ID: 33479752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of simple spectrophotometric and chemometric methods for simultaneous determination of empagliflozin and metformin: Applied to recently approved pharmaceutical formulation.
    Ayoub BM
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Nov; 168():118-122. PubMed ID: 27288963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of Box-Behnken Design and Response Surface Methodology for Selecting the Optimum RP-HPLC Conditions for the Simultaneous Determination of Paracetamol and Diclofenac Sodium Along With Three Skeletal Muscle Relaxants in Three Different Pharmaceutical Dosage Forms.
    Elkady E; Fouad M; Mozayad A
    J Chromatogr Sci; 2024 Apr; 62(4):328-338. PubMed ID: 37525524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plackett-Burman and face-centered composite designs for development and optimization of chromatographic method for the simultaneous determination of glycopyrronium, indacaterol and mometasone in their fixed dose combination inhaler - Green profile assessment.
    Youssef YM; Mahrouse MA; Mostafa EA
    J Pharm Biomed Anal; 2023 Sep; 234():115553. PubMed ID: 37399700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability-indicating chromatographic and chemometric methods for environmentally benign determination of canagliflozin and its major degradation product; A comparative study and greenness assessment.
    Emam AA; Abdelwahab NS
    Biomed Chromatogr; 2019 Oct; 33(10):e4612. PubMed ID: 31152603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of simultaneous determination of empagliflozin and metformin in human plasma using liquid chromatography-mass spectrometry and application to pharmacokinetics.
    Wattamwar T; Mungantiwar A; Halde S; Pandita N
    Eur J Mass Spectrom (Chichester); 2020 Apr; 26(2):117-130. PubMed ID: 31575298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simple TLC-spectrodensitometric method for studying lipophilicity and quantitative analysis of hypoglycemic drugs in their binary mixture.
    Abbas NS; Mohamed YAS; Derayea SM; Omar MA; Saleh GA
    Biomed Chromatogr; 2021 Nov; 35(11):e5154. PubMed ID: 33955025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of a new analytical HPLC method for simultaneous determination of the antidiabetic drugs, metformin and gliclazide.
    Gedawy A; Al-Salami H; Dass CR
    J Food Drug Anal; 2019 Jan; 27(1):315-322. PubMed ID: 30648585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of Metformin and Five Gliptins in Counterfeit Herbal Products: Designs of Experiment Screening and Optimization.
    Salem WA; Elkady EF; Fouad MA; Abdul-Azim Mohammad M
    J AOAC Int; 2021 Dec; 104(6):1667-1680. PubMed ID: 34410406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative determination of potential genotoxic impurity 3-aminopyridine in linagliptin active pharmaceutical ingredient using HILIC-UV.
    Al-Sabti B; Harbali J
    Biomed Chromatogr; 2020 Nov; 34(11):e4930. PubMed ID: 32579716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Versatile Liquid Chromatographic Method for the Simultaneous Determination of Metformin, Sitagliptin, Simvastatin, and Ezetimibe in Different Dosage Forms.
    El-Zaher AA; Elkady EF; Elwy HM; Saleh MAEM
    J AOAC Int; 2018 Mar; 101(2):401-409. PubMed ID: 28748781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SODIUM GLUCOSE COTRANSPORTER 2 AND DIPEPTIDYL PEPTIDASE-4 INHIBITION: PROMISE OF A DYNAMIC DUO.
    Lingvay I
    Endocr Pract; 2017 Jul; 23(7):831-840. PubMed ID: 28332871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous high-performance liquid chromatographic determination of pioglitazone and metformin in pharmaceutical-dosage form.
    Kolte BL; Raut BB; Deo AA; Bagool MA; Shinde DB
    J Chromatogr Sci; 2004 Jan; 42(1):27-31. PubMed ID: 14965412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic drug evaluation of empagliflozin plus linagliptin for the treatment of type 2 diabetes.
    Rizos CV; Filippatos TD; Elisaf MS
    Expert Opin Drug Metab Toxicol; 2018 Jan; 14(1):117-125. PubMed ID: 29241374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empagliflozin/linagliptin single-pill combination therapy for patients with type 2 diabetes mellitus.
    Jain RK
    Expert Opin Pharmacother; 2017 Apr; 18(6):545-549. PubMed ID: 28375658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.